Mentice AB (publ) MN2.F Stock
Mentice AB (publ) Price Chart
Mentice AB (publ) MN2.F Financial and Trading Overview
Mentice AB (publ) stock price | 3.05 EUR |
Previous Close | 3.29 EUR |
Open | 3.26 EUR |
Bid | 3.24 EUR x N/A |
Ask | 3.32 EUR x N/A |
Day's Range | 3.26 - 3.26 EUR |
52 Week Range | 2.88 - 7.2 EUR |
Volume | 100 EUR |
Avg. Volume | 1 EUR |
Market Cap | 83.35M EUR |
Beta (5Y Monthly) | 1.159106 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0.01 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
MN2.F Valuation Measures
Enterprise Value | 87.45M EUR |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | N/A |
Trading Information
Mentice AB (publ) Stock Price History
Beta (5Y Monthly) | 1.159106 |
52-Week Change | -47.70% |
S&P500 52-Week Change | 20.43% |
52 Week High | 7.2 EUR |
52 Week Low | 2.88 EUR |
50-Day Moving Average | 3.65 EUR |
200-Day Moving Average | 3.79 EUR |
MN2.F Share Statistics
Avg. Volume (3 month) | 1 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 25.57M |
Float | 10.98M |
Short Ratio | N/A |
% Held by Insiders | 43.83% |
% Held by Institutions | 38.97% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -10.68% |
Operating Margin (ttm) | 0% |
Gross Margin | 88.27% |
EBITDA Margin | -3.094% |
Management Effectiveness
Return on Assets (ttm) | -3.81% |
Return on Equity (ttm) | -17.040% |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | 22.40% |
Gross Profit (ttm) | 188.94M EUR |
EBITDA | N/A |
Net Income Avi to Common (ttm) | N/A |
Diluted EPS (ttm) | -0.08 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | N/A |
Total Cash Per Share (mrq) | N/A |
Total Debt (mrq) | N/A |
Total Debt/Equity (mrq) | 9.21 EUR |
Current Ratio (mrq) | 1.058 |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | N/A |
Levered Free Cash Flow (ttm) | N/A |
Profile of Mentice AB (publ)
Country | Germany |
State | N/A |
City | Gothenburg |
Address | Odinsgatan 10 |
ZIP | 411 03 |
Phone | 46 20 38 85 16 01 |
Website | https://www.mentice.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 117 |
Mentice AB (publ) provides endovascular simulation technology solutions in Europe, the Middle East, and Africa; Asia and the Asia Pacific region; and the Americas. The company operates through Medical Device Industry, Healthcare Systems, and Strategic Alliances segments. It offers software modules in the areas of acute ischemic stroke intervention, atrial septal defect and patent foramen ovale occlusion, aortic valve implantation, endovascular aortic repair, below-the-knee intervention, carotid intervention, patient-specific simulation, coronary advanced, essential, and intermediate, left atrial appendage occlusion, neurovascular coiling and thrombectomy, peripheral angiography, prostatic artery embolization, radiation safety, renal denervation, renal intervention, thoracic endovascular aortic repair, transarterial chemoembolization, transseptal puncture, uterine artery embolization, peripheral angiography, and vascular trauma and cardiac rhythm management, as well as supports interventionalists to transition from transfemoral to transradial access. The company also provides medical simulators for endovascular therapies, and simulator accessories and extensions for endovascular therapies; silicone vasculature for endovascular simulation; cardiac and vascular flow systems; neurovascular flow systems; mentice right heart cath app, a mobile solution for an interactive real-time exploration into the right heart catheterization procedure; mentice live learning center, a cloud based learning center for medical technology industry and healthcare provider; and angio suites and robotic integrators. Mentice AB (publ) was incorporated in 1998 and is headquartered in Gothenburg, Sweden.
Q&A For Mentice AB (publ) Stock
What is a current MN2.F stock price?
Mentice AB (publ) MN2.F stock price today per share is 3.05 EUR.
How to purchase Mentice AB (publ) stock?
You can buy MN2.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Mentice AB (publ)?
The stock symbol or ticker of Mentice AB (publ) is MN2.F.
Which industry does the Mentice AB (publ) company belong to?
The Mentice AB (publ) industry is Medical Devices.
How many shares does Mentice AB (publ) have in circulation?
The max supply of Mentice AB (publ) shares is 26.65M.
What is Mentice AB (publ) Price to Earnings Ratio (PE Ratio)?
Mentice AB (publ) PE Ratio is 305.00000000 now.
What was Mentice AB (publ) earnings per share over the trailing 12 months (TTM)?
Mentice AB (publ) EPS is 0.01 EUR over the trailing 12 months.
Which sector does the Mentice AB (publ) company belong to?
The Mentice AB (publ) sector is Healthcare.